Lv3
220 积分 2024-11-04 加入
An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies
7天前
已完结
Molecular Mechanisms Involved in Intrarenal Renin-Angiotensin and Alternative Pathways in Diabetic Nephropathy - A Review
7天前
已关闭
Nonproteinuric progressive diabetic kidney disease
7天前
已完结
Terpenoids in Diabetic Nephropathy: Advances and Therapeutic Opportunities
9天前
已完结
Natural Flavonoids: Fortifying Renal Defence Mechanism
11天前
已完结
Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy
16天前
已完结
Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis
16天前
已完结
Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy
16天前
已完结
Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway
16天前
已完结
Astragaloside IV alleviates diabetic nephropathy by modulating the kidney-gut axis AMPK/PI3K/AKT pathway
16天前
已完结
皖公网安备34019202002308
